Evaluation of the cervical cancer screening programme in Mexico: A population-based case-control study

International Journal of Epidemiology

Volumn 27, Issue 3, 1998, Pages 370-376

  Hernández Avila, Mauricio ^a   Lazcano Ponce, Eduardo César ^a   Alonso De Ruíz, Patricia ^b   Romieu, Isabelle ^c  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b CITY GENERAL HOSPITAL   (United Kingdom)

^c Pan American Health Organization   (Mexico)

Author keywords

Cervical cancer; Epidemiology; Papanicolaou; Screening

Indexed keywords

CANCER; HEALTH SURVEY; MONITORING;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SCREENING; CARCINOMA IN SITU; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MEXICO; NORMAL HUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

MEXICO; MEXICO CITY;

EID: 2642646227     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/27.3.370     Document Type: Article

References (34)

1. Boring C, Squires T, Tong T. Cancer Statistics 1992. Ca A Cancer Journal for Clinicians 1992;42:19-38.
2. Lazcano-Ponce E, Rascon-Pacheco R, Lozano-Ascencio R, Velasco E. Mortality from carcinoma of the uterine cervix in Mexico: Impact of screening 1980-1990. Acta Cytol 1996;40:506-512.
3. Johannesson G, Geirsson G, Day NE. The effect of mass screening in Iceland, 1965-1974, on the incidence and mortality of cervical carcinoma. Int J Cancer 1978;21:418.
4. Boyes DA, Nichols TM, Millner AM, Worth AJ. Recent results from the British Columbia Screening Program for Cervical Cancer. Am J Obstet Gynecol 1977;128:692.
5. Restrepo HE, Gonzalez JL, Roberts E, Litvak J. Epidemiología y control del cáncer del cuello uterino en America Latina y el Caribc. Bol Of Sanit Panam 1987;102:578.
6. Papanicolaou GN, Traut HF. The diagnostic value of vaginal smears in carcinoma of the uterus. Am J Obstet Gynecol 1941;42:193.
7. Logros de la campaña Nacional contra el Cáncer (editorial). Salud Pública Mex 1976;13:5-6.
8. García G. Ia detección de cáncer del cuello uterino en 75,855 mujeres. Gac Med Mex 1970;100:154.
9. Ordoñez BR. Avances en la prevención del cáncer cervicouterino en el Instituto Mexicano del Seguro Social. Salud Pública Mex 1971;13: 327.
10. Alvarez Alva R, Ordóñez B. Detección del cáncer cervicouterino. Salud Pública Mex 1970;12:137-40.
11. Norma Oficial Mexicana NOM-014-SSA2-1994, Para la prevención, tratamiento y control de cáncer del cuello del útero y de la mama en la atención primaria. México: Secretaría de Salud, 1994.
12. Gutiérrez G, Sepúlveda J, Tapia R, Pérez R, Solachi G, Valdespino JL. Encuesta nacional Seroepidemiológica. I. Diseño conceptual y metodología. Salud Pública Mex 1988;30:836-52.
13. Lazcano Ponce E, Rojas R, López Acuña MP, López Carrillo L, Hernández Avila M. Factores reproductivos y riesgo de cáncer cervicouterino en mujeres de la ciudad de México. Salud Pública Mex 1993;35:65-73.
14. La Vecchia C, Franseschi S, Decarli A, Fasoli M, Gentile A, Tognoni G. Pap smear and the risk of cervical neoplasia: Quantitative estimates from a case control study. Lancet 1984;i:779-82.
15. SAS Institute Inc. SAS/STAT user's guide. Cary, version 6. Cary, NC: SAS Institute Inc., 1987.
16. Statistics and Epidemiology Research Corporation. EGRET: Epidemiological graphics, estimation and testing package. SERC,909 NE 3ed, suite 310, Seattle, WA 98015.
17. Bronfman M, Guiscafre H, Castro R et al. Estrategias para mejorar los patrones terapeuticos utilizados en diarrea aguda en unidades de atención médica primaria. II. Medición de la desigualdad: una propuesta metodológica, análisis de las características socioeconómicas de la muestra. Arch Invest Med (Mex) 1988;19:351-60.
18. Kleinbaum DG, Kupper LL, Muller K. Applied Regression Analysis and Other Multivariable Methods. Boston: PWS-Kent Publishing Co., 1988.
19. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989;79:340-49.
20. Walter S. The estimation and interpretation of attributable risk in health research. Biometrics 1976;32:829-49.
21. Clarke EA, Anderson TW. Does screening by "Pap" smear help prevent cervical cancer? A case-control study. Lancet 1979;ii:14.
22. Hougen A. Mass screening for cancer of the uterine cervix in the county of Osffold, Norway. In: Nieburgs HE (ed.). Prevention and Detection of Cancer. New York: Dekker, 1980, pp. 1975-84.
23. Boyes DA, Worth AJ, Anderson GH. Experience with cervical screening in British Columbia. Ginecol Oncol 1981;12:S143-S155.
24. Geirsson G, Kristiansdottir R, Sigurdsson K et al. Cervical cancer screening in Iceland: A case-control study. In: Hakama M, Miller AB, Day NE (eds). Screening for Cancer of the Uterine Cervix. Lyon: International Agency for Research on Cancer, 1986, pp.37-41.
25. Berrino F, Gatta G, d'Alto M et al. Efficacy of screening in preventing invasive cervical cancer: a case-control study in Milan, Italy. In: Hakama M, Miller AB, Day NE (eds). Screening for Cancer of the Uterine Cervix. Lyon: International Agency for Research on Cancer, 1986, pp.111-23.
26. Raymand L, Obradovic M, Riotton G. Une etude cas-temoins pour l'evaluation du dépistage cytologique du cancer du col uterin. Rev Epidemiol Sante Publique 1984;32:10-15.
27. Aristizabal N, Cuello C, Correa P et al. The impact of vaginal cytology on cervical cancer risks in Cali, Colombia. Int J Cancer 1984;34:5-9.
28. MacGregor JE, Moss SM, Parkin DM, Day NE. A case-control study of cervical cancer screening in north east Scotland. Br Med J 1985; 290:1543-16.
29. Pettersson F, Bjorkholm E, Naslund I. Evaluation of screening for cervical cancer in Sweden: Trend in incidence and mortality 1958-1980. Int J Epidemiol 1985;14:521-27.
30. Lynge E, Poll P. Incidence of cervical cancer following negative smear. A cohort study from Maribo County, Denmark. Am J Epidemiol 1986; 124:345.
31. Choi NW, Nelson NA. Results from a cervical cancer screening programme in Manitoba, Canada. In: Hakama M, Miller AB, Day NE (eds). Screening for Cancer of the Uterine Cervix. Lyon: International Agency for Research on Cancer, 1986, p.61-67.
32. IARC Working Group on Evaluation of Cervical Cancer Screening Programs. Screening for squamous cervical cancer: Duration of low risk after negative results of cervical cytology and its implication for screening policies. Br Med J 1986;293:659-64.
33. Celentano D, Klassen A, Weisman C, Rosenshein N. Duration of relative protection of screening for cervical cancer. Prev Med 1989; 18:411-22.
34. Herrero R, Brinton L, Reeves W et al. Screening for cervical cancer in Latin America: A case-control study. Int J Epidemiol 1992;21:1050-56.